Metropolitan Digital

Men's Weekly


.

FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face

  • Written by Benjamin Y. Fong, Honors Faculty Fellow, Associate Teaching Professor, and Associate Director of the Center for Work & Democracy, Arizona State University
FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics faceA growing body of evidence points to MDMA's therapeutic potential for managing an array of hard-to-treat conditions like PTSD and depression.Antonio Ciufo/Moment via Getty Images

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of...

Read more: FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges...

More Articles ...

  1. Dementia risk factors identified in new global report are all preventable – addressing them could reduce dementia rates by 45%
  2. A bipartisan data-privacy law could backfire on small businesses − 2 marketing professors explain why
  3. New storm is headed for the Caribbean: What meteorologists look for in early signs of a future hurricane
  4. At its core, life is all about play − just look at the animal kingdom
  5. Could dinosaurs still exist somewhere in the world? A paleontologist explains
  6. Why is an ultimate goal called a ‘Holy Grail?’
  7. If you want Americans to pay attention to climate change, just call it climate change
  8. Wagner Group setback in Mali challenges Moscow’s strategy in Africa and the region’s faith in Russian mercenaries
  9. A packed Baltimore trolley illustrates the ups and downs of US public transit
  10. Rat poison is moving up through food chains, threatening carnivores around the world
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more